SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001206774-08-000531
Filing Date
2008-03-17
Accepted
2008-03-17 16:05:45
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT avigen_10k.htm 10-K 1106296
2 GRAPHIC avigen_10k3x2x1.jpg GRAPHIC 13596
3 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO. LLP, INDEPENDENT REGISTERED PUBLI exhibit23-1.htm EX-23.1 2170
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit23-2.htm EX-23.2 2070
5 CEO CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) exhibit31-1.htm EX-31.1 7354
6 CFO CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) exhibit31-2.htm EX-31.2 7294
7 CERTIFICATION REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) AND SECTION 1350 exhibit32-1.htm EX-32.1 3662
  Complete submission text file 0001206774-08-000531.txt   1149138
Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Filer) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28272 | Film No.: 08693027
SIC: 2835 In Vitro & In Vivo Diagnostic Substances